Today: 9 June 2026
Arby’s quietly closes more locations as fast-food chains retrench into 2026
30 December 2025
1 min read

Arby’s quietly closes more locations as fast-food chains retrench into 2026

NEW YORK, December 29, 2025, 18:26 ET

  • Arby’s is quietly closing some restaurants, according to recent media reports.
  • The roast-beef sandwich chain has not issued a broad public list of affected stores.
  • The pullback adds to a wider push by fast-food brands to trim underperforming locations as costs rise and consumers cut back.

Arby’s is quietly closing some restaurant locations in the United States, renewing questions about how the 60-year-old sandwich chain is navigating an uneven fast-food market.

The issue matters now because restaurant operators are heading into 2026 with customers still sensitive to price increases, while labor and rent remain elevated. For franchise-heavy chains, closures can quickly reshape local competition and shift sales to nearby stores.

It also underscores how even established brands are tightening their footprints as they chase higher average sales per restaurant. Wendy’s interim CEO Ken Cook, announcing a separate wave of store shutdowns, said some locations “do not elevate the brand and are a drag,” as the chain moves to cut underperformers.

Arby’s has not made a broad announcement about closures, but at least 14 restaurants have shut in 2025, with closures reported across California, Delaware, Florida, Maryland, New Jersey, South Carolina, Tennessee and Washington, food site Allrecipes reported. The outlet also cited rising costs for food, labor and rent as pressures across the sector.

A Newsweek report detailing closures said the impacts this year have been most visible in pockets such as Tennessee, with shutdowns reported in Cordova, Germantown and Memphis, and another in Murfreesboro earlier in the year. It also cited closures in places including Fresno and Victorville in California, Talleyville in Delaware, Laurel in Maryland, Audubon in New Jersey, Pullman in Washington state and North Charleston in South Carolina.

Arby’s was founded in 1964 and built its brand around roast beef sandwiches and a menu that leans heavily on sandwiches and sides.

The chain sits inside Inspire Brands, a private restaurant group that also owns Dunkin’, Jimmy John’s, Sonic Drive-In, Buffalo Wild Wings and Baskin-Robbins, according to published company background.

Most Arby’s restaurants are franchised, meaning local operators run stores under the brand and pay fees and royalties. That structure can make closures appear “quiet” when a franchisee shuts an individual store without a companywide announcement.

For consumers, the shift is already changing choices in some markets, especially where Arby’s operates a smaller number of locations and closures remove a nearby option rather than thinning an oversupplied area.

In the sandwich category, Arby’s remains a sizable player despite the closures, competing for traffic against chains led by Subway and Panera, with rivals including Jersey Mike’s and Jimmy John’s also jostling for share.

The immediate question is whether the company or its franchisees provide more clarity on which stores are affected as 2025 ends, and whether the pace of closures continues into the first quarter of 2026.

Stock Market Today

  • Soybean Prices Decline Amid Lower Export Shipments and Reduced Speculative Positions
    June 9, 2026, 9:21 AM EDT. Soybean prices fell between 2 and 5 ½ cents on Monday, with the national average cash price dropping to $10.58 3/4 per bushel. Export shipments for the week ending June 4 decreased by 21.2% from the previous week, totaling 398,186 MT, and are down 28.8% year-over-year. Key buyers included Egypt, China, and Mexico. Marketing year exports stand 20.3% lower compared to last year. Meanwhile, speculative traders reduced their net long positions in soybean futures and options by 33,502 contracts, signaling cautious market sentiment. Soymeal and soy oil futures also declined modestly. A private export sale of 264,000 MT was reported for the 2026/27 season, but overall market pressure weighs on prices going into the week.

Latest articles

AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

9 June 2026
AT&T shares edged up to $22.58 pre-market after reaffirming 2026 guidance and a $45B+ shareholder return plan, providing a cash-flow marker as satellite broadband competition looms; the stock remains pressured by SpaceX risks flagged by Oppenheimer, with second-quarter free cash flow seen at $4.0–$4.5B.
GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

9 June 2026
GSK will buy Nuvalent for $10.6 billion in cash, paying a 40% premium, to boost its oncology pipeline ahead of looming HIV drug patent expiries; Nuvalent shares jumped 38.9% premarket while GSK fell 1.4%, with the deal expected to add to GSK sales and profit from 2027 but dilute earnings per share 2026-2028 if it closes in Q3, and final outcome depends on FDA approvals and regulatory clearance.
AmpliTech’s 5G Radio Test Moves AMPG Shares

AmpliTech’s 5G Radio Test Moves AMPG Shares

9 June 2026
AMPG soared 26.7% to $6.57 after AmpliTech revealed its 64T64R Massive MIMO radio was the only one of its kind at O-RAN PlugFest, showing interoperability with major carriers’ equipment, but no new orders were announced, leaving sales conversion as the key investor focus.
Cartesian Growth Ticker Change Draws Trader Attention to Factorial Energy

Cartesian Growth Ticker Change Draws Trader Attention to Factorial Energy

9 June 2026
Factorial Energy surged 16% to $13.80 in its Nasdaq debut as FAC, with premarket trading near $20.70, after replacing CGCT via SPAC merger that raised over $100 million for battery commercialization and implied a $1.3 billion equity value; former CGCT shares now trade as FAC, with founders retaining majority voting power and staged lock-up releases ahead.
Pfizer Falls in Premarket; Fresh FDA Approval Not Lifting the Stock

Pfizer Falls in Premarket; Fresh FDA Approval Not Lifting the Stock

9 June 2026
Pfizer shares fell 1.7% premarket to $25.62 as investors weighed an FDA label expansion for hemophilia drug Hympavzi—now the first subcutaneous non-factor therapy for children 6-11 with hemophilia B—against slower progress in obesity drugs, with mid-stage data for weight-loss shot berobenatide showing a 23.3% vomiting rate and no immediate growth catalyst for the $147 billion company.
AMD stock today: Shares tick higher after hours as year-end tech selling weighs on chipmakers
Previous Story

AMD stock today: Shares tick higher after hours as year-end tech selling weighs on chipmakers

SELLAS Life Sciences (SLS) stock jumps on Phase 3 AML trial timing update — what investors watch next
Next Story

SELLAS Life Sciences (SLS) stock jumps on Phase 3 AML trial timing update — what investors watch next

Go toTop